Summary In this paper we investigate the reactivity pattern of T cells from stomach carcinoma patients against autologous tumour cells. T cells obtained from the tumour environment, tumour-draining lymph nodes and peripheral blood were cloned in 78 patients with stomach cancer and anti-tumour cytotoxic T lymphocytes (CTLs) precursor frequencies were assessed in each sample by using limiting dilution analysis. When tumour-specific CTLs were tested for specific T-cell killing by using only low doses of Interleukin 2 (100 U ml-'), a moderate rate of proliferation frequency of T cells (0.047) and specific cytotoxicity (12%) were observed in lymph node populations. When both IL-2 and autologous tumour cells in mixed lymphocyte tumour cultures (MLTCs) were used for stimulation, a dramatic increase in number (0.1) and in specific lytic activity (46%) could be measured. No effect or specific activity to tumour cells was observed with peripheral blood lymphocytes and tumour-infiltrating lymphocytes.
Most investigations of T-cell reactivity to tumours have up until now concentrated on melanomas. This is a good model of cellular reaction to tumour-associated immunogenic structures (Anchini et al., 1987 (Anchini et al., , 1989 Muul et al., 1987; Topalian et al., 1989) and one in which immunotherapies have proved effective (Rosenberg et al., 1986) . Only a few other spontaneous tumours have been analysed, and only a few reports (Nakamura et al., 1988; Mukhopadhyaya et al., 1989; Tatake et al., 1989 ) have compared immune responses between lymphocytes isolated from peripheral blood, regional lymph nodes and tumours in different malignant diseases. Most deal with lymphokine-activated killer (LAK) cells (Itoh et al., 1986; Rabinowich et al., 1987) and cytotoxic T lymphocytes (CTLs) originating from melanomas (Muul et al., 1987; Anchini et al., 1989; Topalian et al., 1989) . In many cases, it has been reported that tumours themselves McLemore et al., 1988; Floutsis et al., 1989; Kuppner et al., 1989 Kuppner et al., , 1990 or tumour-infiltrating suppressor cells (North et al., 1985; Mukherji et al., 1986a,b) inhibit the proliferation and function of T lymphocytes. Herin et al. (1987) , Uchida et al. (1988) and Gervois et al. (1990) showed in their experiments that mixed lymphocyte tumour cultures (MLTCs) can propagate the growth of tumour-specific cytotoxic T cells in vitro.
Stomach carcinoma is still one of the most frequent cancers worldwide with a very poor prognosis (Correa, 1985) and relatively unknown aetiology. Furthermore, most likely owing to the long development of these spontaneous tumours, a down-regulation of host immune response has been observed Miescher et al., 1987; Belldegrun et al., 1988) . The proliferation capacity of immune cells from tumour patients seems to be very poor (Miescher et al., 1988a,b) , making it difficult to investigate reactivity patterns of T cells from stomach cancer.
In this study we raised and analysed tumour-specific CTLs obtained from stomach carcinoma patients.
Materials and methods

Patients
Seventy-eight different stomach tumour resections from 78 German patients between the ages of 29 and 83 (mean 65 years) were used in our study (Table I) . We obtained only one tumour from every patient. In 46 cases the clinical resections included the spleen. From 64 patients lymph nodes had been resected and from 14 we received no lymph node material. Blood was obtained from 38 patients prior to operation. The lymphocytes from one source (tumour, blood, spleen or lymph node) each tested as a separate population. None of the patients had received chemotherapy before resection.
Isolation of lymphocytes and tumour cells Peripheral blood lymphocytes (PBLs) Heparinised blood obtained prior to the operation was diluted 1:1 with RPMI-1640 (Biochrom, Germany). Mononuclear cells were isolated by Ficoll-Hypaque (Biochrom) density gradient. A 25 ml volume of diluted blood overlayered on 15 ml of Ficoll (D = 0.0177) was centrifuged at 700 g for 20 min at room temperature. Cells from the interphase were collected and washed twice in RPMI-1640.
Regional lymph node lymphocytes (RLNLs) Regional lymph nodes, harvested from resection, were minced and pressed through a 100 gm nylon mesh (Nybolt, Switzerland). The suspended cells were washed twice in 10 ml of RPMI + 10% fetal calf serum (FCS) (Biochrom) + 50 sg ml-' gentamycin (Biochrom).
Tumour-infiltrating lymphocytes (TILs) The tumour pieces from 78 tumours were minced, crushed on a glass slide, passed through a 100 iLm stainless-steel mesh and washed in phosphate-buffered saline (PBS) according to the method of Vose (1982) . The remaining tissue was treated with collagenase II (Sigma, Germany) and DNAse I (Sigma) according to Slocum et al. (1983) . Cell suspensions were then Owing to the low proliferative T-cell precursor frequency obtained in these samples, and according to a formula described in Taswell Determination offrequencies ofproliferating T-cell precursors by limiting dilution analysis Precursor frequencies were obtained by calculating and drawing a straight line which describes the relationship between number of seeded cells per well and the logarithm of the fraction of non-proliferating (negative) microcultures. According to the single-hit Poisson model, the cell dose (x-axis) containing on the average one proliferating T cell is given by the intercept of the straight titration line by the ordinate value 0.37. Positive/negative responses were the presence/ absence of growing T cells in a well at the highest three dilutions. Results were calculated using a program established and described in more detail by Taswell (1981) .
Culture of T-cell clones Obtained clones were cultured in RPMI with 10% FCS and antibiotics supplemented with 50 IU ml-' rIL-2. The addition of irradiated (5,000 rad) autologous tumour cells every 2 weeks in an effector-target (E/T) ratio of 10: 1 was necessary to maintain growth of the specific clones.
Target cells
Six different stomach carcinoma cell lines, the natural killer cell (NK)-sensitive cell line K562 and the NK-resistant cell line Daudi were used as allogenic target cells in cytotoxic assay and MLTC (Table II) . All lines were obtained from metastatic stomach tumours after isolation and culturing as described above. PHA-blasts were generated by stimulation of freshly isolated autologous lymphocytes from blood or spleen in medium supplemented with 1% PHA (Gibco) for 3 days, washed and used as target cells after labelling with 5'Cr.
Cytotoxic assay
The cytotoxic activity of T-cell clones was tested for cytotoxic activity against 5'Cr-labelled target cells according to the method of Brunner et al. (1976 
Results
Specific cytotoxicity
The recovery of lymphocytes differed in all 78 biopsies (from 0.3 x 106 to 1.6 x 107). We could not observe any correlation between type and stage of tumour, age of the patient and yield of viable lymphocytes. The main point of our investigation was to establish T-cell clones with the ability to lyse specifically autologous tumour cells (Figure 1 ). No lysis of allogeneic tumour cells and autologous blasts could be detected.
We found these specific cytotoxic T-cell clones in all six tested patients in the lymph node compartment. Prior to co-culturing, the frequency of cytotoxic precursor T cells in RLNLs reached the level of 0.047 (16 clones, Figure 2 ) and the specific lysis of these T-cell clones was very low (12%, E/T ratio 10:1; Figure 1 . NK activity measured by lysis of NK-sensitive cell line K562 reached 21%.
However, cloning after MLTC resulted in an increase in frequency (up to 0.1, 35 clones; Figure 2 ) and in the lysis of the autologous tumour cells (up to 47%; Figure 1 ) by specific T-cell clones. Moderate NK activity of 11% could be detected. We observed this effect only with lymph node lymphocytes. In PBLs or TILs using the same cloning conditions and cloning prior to and after MLTCs, we found no T-cell clones with specific lysis. Only a few clones with unknown specificity will grow.
Limiting dilution Limiting dilution analysis was used to calculate the proliferation capacity of T cells from different sources with the following results. The frequency of proliferating T cells in the TIL fraction was moderate -often less than 3% (F = 0.03) of cells were able to proliferate. In contrast to TILs, lymphocytes from regional lymph nodes showed a higher rate of proliferating T cells (8 to 10-fold). A reduced ratio growth (F = 0.17) could also be observed in patients' PBLs as compared with 50-100% (mean = 0.73) in normal control PBL T cells (Figure 3) .
No influence of MLTC on precursor frequency of T cells could be observed in RLNLs. Immunofluorescence analysis of a stimulated T-cell clone
The expression of IL-2 receptor increased only on stimulation with autologous tumour cells (Figure 4d ). With medium alone (Figure 4a ) with the autologus EBV cell line ( Figure  4b ) or with the allogenic tumour cell line 23132 (Figure 4c ) no or limited stimulation could be observed.
Proliferation of clones after stimulation with different cells
We tested four resting clones from patient 23132 derived from the lymph node compartment. After stimulation with autologous tumour cells we could detect proliferation expressed by incorporation of [3H]thymidine ( Figure 5 ). The stimulations culminated in a maximum proliferation response of stimulated clones at a ratio between 1: 1 and 5:1 responder cells to tumour cells. We observed no effect by adding allogenic tumour cells or autologous spleen cells.
Restimulation of the clones with autologous tumour cells was necessary to produce proliferating cells. The application of low-dose IL-2 (10 U ml-') alone was not sufficient to obtain highly proliferating clones. This means that the proliferation of these specific cytotoxic T cells is dependent on IL-2 production of stimulated associated T-helper clones.
Blocking experiments of specific cytotoxicity with monoclonal antibodies Different monoclonal antibodies were used to block the specific lysis of the autologous tumour cells by the four investigated T-cell clones to detect the restriction elements of binding of these clones to the target cells. The upper graph in Figure 6 shows the blocking efficiency of the antibodies against the T-cell receptor-associated protein CD3 and the CD8 protein. We observed similar blocking effects with both antibodies.
Preincubation of the tumour cells with antibodies against MHC class I (HLA-ABC) reduced the cytotoxicity dramatically ( Figure 6 , lower graph). The antibody against class II showed no blocking effects.
Discussion
This is the first study analysing T-cell reactions in stomach cancers under cloning conditions. We were able to show that it is possible to expand CD8+ T-lymphocyte clones specific for autologous tumour cells with high levels of lytic activity. Only in cultures of human lymph node lymphocyte populations and with mixed lymphocyte tumour cultures could specific cytotoxic clones be generated.
Many authors describe the low proliferation frequency in different types of tumour Miescher et al., 1987; Belldegrun et al., 1988; Anchini et al., 1989) . Using immunohistochemical techniques we observed either a loss of or low levels of IL-2 receptor in TILs in the tumours (data not shown).
The low capacity for proliferation of lymphocytes from cancer patients complicates the analysis of the T-cell reactions. Our observations of low proliferation of all tested lymphocytes from tumour patients confirmed the data from Whiteside et al. (1986) FACS analysis (Figure 4 ) of the specific T cells showed that the expression of IL-2 receptor increased after stimulation only with autologous tumour cells. This specificity could also be shown in proliferation tests ( Figure 5 ). Without addition of IL-2 only a low rate of proliferation could be observed, pointing to dependence on lymphokine production of associated stimulated T-helper clones.
By using blocking experiments we could identify the restriction elements on the reacting T-cell clones as the T-cell receptor (CD3) together with the CD8 molecule. This complex reacts with the HLA-ABC surface antigen and an unknown tumour antigen on the target tumour cells. Wolfel et al. (1989) were able to identify HLA-A2 as the restricting element for lysis melanoma by specific T-cell clones in their study. Furthermore, Van der Bruggen et al. (1991) described the first gene encoding a melanoma-specific antigen called MAGE-1 which is restricted by HLA-A1. We found tumour-specific T cells only in lymph nodes and not in the tumour or in the blood. This is probably due to suppressor factors produced by tumour cells and released in the tumour microenvironment which suppress the proliferation of tumour-specific T cells.
However, we did observe tumour-reactive T cells in tumour-draining lymph nodes. We think that tumour cells might have a stimulating effect on specific T-cell immunity, but we could only select these cells by MLTCs. Further investigations are needed to prove this theory.
